RO4927350 50mg 50mg | Purity Not Available
Adooq Bioscience
RO4927350 a potent and highly selective non-ATP-competitive MEK1/2 inhibitor.
More Information Supplier PageSearch Results
RO4927350 5mg 5mg | Purity Not Available
Adooq Bioscience
RO4927350 a potent and highly selective non-ATP-competitive MEK1/2 inhibitor.
More Information Supplier PageRO4927350 25mg 25mg | Purity Not Available
Adooq Bioscience
RO4927350 a potent and highly selective non-ATP-competitive MEK1/2 inhibitor.
More Information Supplier PageGW842166X 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain
More Information Supplier PageGW842166X 25mg 25mg | Purity Not Available
Adooq Bioscience
GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain
More Information Supplier PageEMD-1214063 50mg 50mg | Purity Not Available
Adooq Bioscience
EMD-1214063 is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. It binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase.
More Information Supplier PageEMD-1214063 5mg 5mg | Purity Not Available
Adooq Bioscience
EMD-1214063 is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. It binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase.
More Information Supplier PageEMD-1214063 100mg 100mg | Purity Not Available
Adooq Bioscience
EMD-1214063 is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. It binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase.
More Information Supplier PageEMD-1214063 10mg 10mg | Purity Not Available
Adooq Bioscience
EMD-1214063 is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. It binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase.
More Information Supplier PageMK-0974 50mg 50mg | Purity Not Available
Adooq Bioscience
MK-0974 (Telcagepant) is a potent and selective antagonist of the human and rhesus CGRP receptors.
More Information Supplier Page